Cargando…
Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
INTRODUCTION: Despite widespread use of second-generation cholinesterase inhibitors for the symptomatic treatment of Alzheimer’s disease (AD), little is known about the long term effects of cholinergic treatment on global cognitive function and potential specific effects in different cognitive domai...
Autores principales: | Behl, Pearl, Edwards, Jodi D, Kiss, Alexander, Lanctot, Krista L, Streiner, David L, Black, Sandra E, Stuss, Donald T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255390/ https://www.ncbi.nlm.nih.gov/pubmed/25484926 http://dx.doi.org/10.1186/alzrt280 |
Ejemplares similares
-
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021) -
White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease
por: Desmarais, Philippe, et al.
Publicado: (2021) -
Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts
por: Lim, Andrew S. P., et al.
Publicado: (2018) -
Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
por: Wu, Che‐Yuan, et al.
Publicado: (2020) -
The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
por: Ouk, Michael, et al.
Publicado: (2021)